Same Indication

Erlotinib vs Vemurafenib

Erlotinib vs Vemurafenib: Overview

This comparison examines the pharmacological differences between Erlotinib and Vemurafenib.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Erlotinib β€” 36 hours.

Chemical Properties

Molecular Formula: Erlotinib β€” C22H23N3O4.

Molecular Weight: Erlotinib β€” 393.4380 g/mol.

Type: Erlotinib β€” Small molecule; Vemurafenib β€” Small molecule.